Sergey Brin Invests $15M in Ibogaine Trials

2 years ago

Google co-founder Sergey Brin is funding the development of a hallucinogen derived from a rainforest shrub for mental health treatment, marking a notable Silicon Valley move into the burgeoning psychedelics sector. Catalyst4, Brin’s non-profit investment vehicle established with proceeds from his 2021 Tesla stake sale, is committing around $15 million of a $25 million funding […]